Clinical Trial Detail

NCT ID NCT03701308
Title Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin

Cytarabine + Uproleselan

Cytarabine + Daunorubicin + Uproleselan

Cytarabine

Age Groups: adult senior

Additional content available in CKB BOOST